Importance of neutrophil/lymphocyte ratio in prediction of PSA recurrence after radical prostatectomy

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 5, 2015, Pages 1813-1816

  Gazel, Eymen ^a   Tastemur, Sedat ^a   Acikgoz, Onur ^a   Yigman, Metin ^a   Olcucuoglu, Erkan ^a   Camtosun, Ahmet ^a   Ceylan, Cavit ^a   Ates, Can ^b  

^a Turkey Yuksek Ihtisas Training and Research Hospital   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

NLR; Prostate cancer; Prostatectomy; PSA; Recurrence

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; BLOOD; CYTOLOGY; HUMAN; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

AGED; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84928542732     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.5.1813     Document Type: Article

References (24)

1. Cetin B, Berk V, Kaplan MA, et al (2013). Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastaticrenal cell carcinoma? Clin Genitourin Cancer, 11, 141-8.
2. Ceylan C, Doluoglu OG, Keles I,et al (2014). Importance of the neutrophil-to-lymphocyte ratio in muscle-invasive and non-muscle invasive bladder tumors. Urologia, 81, 120-4.
3. De La Roca RL, Da Cunha IW, Bezerra SM, Da Fonseca FP (2014). Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome. Int Braz J Urol, 40, 306-15.
4. Eerola AK, Soini Y, Paakko P (2006). A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res, 6, 1875-81.
5. Fichtner J (2000).The management of prostate cancer in patients with a rising prostate-specific antigen level. BJU Int, 86, 181-90.
6. Fondevila C, Metges JP, Fuster J et al(2004). P53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer, 90, 206-15.
7. Hermanns T, Bhindi B, Wei Y, et al (2014). Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radicalcystectomy for urothelial carcinoma of the bladder. Br J Cancer, 29, 444-51.
8. Kang M, Jeong CW, Choi W, et al (2014). Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer. PLoS One, 17, 100053.
9. Keizman D, Gottfried M, Ish-Shalom M, et al (2012). Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram. Oncologist, 17, 1508-14.
10. Kishi Y, Kopetz S, Chun YS, et al (2009). Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol, 16, 614-22.
11. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH (2003). Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis, 6, 283-87
12. Naito S (2010). Evaluation and management of prostate-specific antigenrecurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol, 35, 365-74.
13. Nuhn P, Vaghasia AM, Goyal J, et al (2013). Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients withmetastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel. BJU Int.
14. Ohno Y, Nakashima J, Ohori M, Hatano T, Tachibana M (2010). Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol, 184, 873-78.
15. Ozyalvacli G, Yesil C, Kargi E, et al (2014).Diagnostic and prognostic importance of the neutrophil lymphocyte ratio in breast cancer. Asian Pac J Cancer Prev, 15, 10363-6.
16. Plonis J, Bokums K, Cauce V, et al (2014). Prostate cancer trends in Latvia during 1990-2012: Incidence, prevalence, mortality, and survival rates. Medicina, 50, 313-7.
17. Ploussard G, Agamy MA, Alenda O, et al (2011). Impact of positive surgical margins on prostate-specific antigen failure after radicalprostatectomy in adjuvant treatment-naïve patients. BJU Int, 107, 1748-54.
18. Shebl FM, Hsing AW, Park Y, et al (2014). Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study. PLoS One, 9, 114633.
19. Sonpavde G, Pond GR, Armstrong AJ, et al (2014). Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer. Clin Genitourin Cancer, 14, 54-8.
20. Sumbul AT, Sezer A, Abali H, et al (2014). Neutrophil-to lymphocyte ratio predicts PSA response, but not outcomes in patients with castration resistantprostate cancer treated with docetaxel. Int Urol Nephrol, 46, 1531-5.
21. Tanaka N, Fujimoto K, Hirayama A, et al (2011). Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study. Int J Clin Oncol, 16, 553-9.
22. Tanik S, Albayrak S, Zengin K, et al (2014). Is the neutrophil-lymphocyte ratio an indicator of progression in patients with benign prostatic hyperplasia? Asian Pac J Cancer Prev, 15, 6375-9.
23. Teeter AE, Presti JC Jr, Aronson WJ, et al (2013). Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group. Urology, 82, 53-8.
24. Wei Y, Jiang YZ, Qian WH (2014). Prognostic role of NLR in urinary cancers: a meta-analysis. PLoS One, 18, 92079.